Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's foreign and domestic oversight powers would increase under the legislation, which has been stripped down in an apparent effort to speed passage.
You may also be interested in...
GMP Third-Party Audits Offered In Draft Senate User Fee Legislation
Bipartisan group of senators unveils several draft provisions of user fee legislation, including a program to allow third-party auditors to evaluate manufacturing facility compliance with U.S. standards for drugs.
USP To Bring Global Perspective To Track And Trace Discussion
The U.S. Pharmacopeial Convention released a framework Jan. 4 for instituting supply chain security measures and plans a May workshop with speakers from other countries to discuss their programs for tracking drug components and products through distribution channels.
USP To Bring Global Perspective To Track And Trace Discussion
The U.S. Pharmacopeial Convention released a framework Jan. 4 for instituting supply chain security measures and plans a May workshop with speakers from other countries to discuss their programs for tracking drug components and products through distribution channels.